Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119Dean A. Wacker, Jeffrey A. Robl, Steven O’Connor et al.|Journal of Medicinal Chemistry|2014Cited by 46
Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice modelYanling Ma, Dong Cheng, Hong Cai et al.|Journal of Lipid Research|2024Cited by 14